Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05756257 · ClinicalTrials.gov registry record

Blood Pressure Variability and Ischemic Stroke Outcome

A clinical trial of Acute Ischemic Stroke and Blood Pressure Variability, sponsored by Yale University.

Recruiting
Registry status
150
Enrollment target
3
Study locations

NCT05756257 is a study of Acute Ischemic Stroke and Blood Pressure Variability that is actively recruiting participants, run by Yale University. The registered enrollment target is 150 participants, below the 346-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (57% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05756257, a study of Acute Ischemic Stroke and Blood Pressure Variability, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
150 participants
Enrollment target
3
Study locations

Study Summary

The goal of this observational study is to evaluate the role of blood pressure (BPV) variability in patients suffering from acute ischemic stroke. The main questions it aims to answer are: 1. To determine the association of BPV with functional/cognitive outcome after ischemic stroke. 2. To determine a pathophysiologic mechanism of BPV's deleterious effect on functional outcome. 3. To evaluate potential treatment targets to pharmacologically reduce BPV after ischemic stroke.

Study Locations (3)

Connecticut

  • Yale-New Haven Hospital - New Haven

Illinois

  • University of Chicago Medical Center - Chicago

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-07-15
Est. Completion 2026-03-30

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT05756257

The ClinicalTrials.gov registry entry for NCT05756257 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 346-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (57% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT05756257 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Connecticut, Illinois, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05756257 about?

NCT05756257 is a clinical study titled "Blood Pressure Variability and Ischemic Stroke Outcome". The goal of this observational study is to evaluate the role of blood pressure (BPV) variability in patients suffering from acute ischemic stroke. The main questions it aims to answer are: 1. To determine the association of BPV with functional/cognitive outcome after ischemic stroke. 2. To determin...

What is the current status of trial NCT05756257?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2024-07-15. Estimated completion is 2026-03-30.

What conditions does trial NCT05756257 study?

This clinical trial studies the following conditions: Acute Ischemic Stroke, Blood Pressure Variability.

Who is sponsoring clinical trial NCT05756257?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05756257 being conducted?

This trial has 3 study locations across Connecticut, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.